What To Know
- A list of companies that received their first FDA 510(k) clearances and companies that received their first 510(k) clearance in a new market segment, as well as details on the company’s product and headquarter country.
- 2018 revenue estimates and market share for the top players in each market segment (joint replacement knee, hip, and extremities.
2020 Orthopedic Market Report report is the definitive source for orthopedic market intelligence.
Special Features of the 2020 Installment Include:
- COVID-19 Impact and Recovery Insights
- Data for Companies with Revenue >$100 Million
- Bonus Excel File of Raw Numbers
Within this report, you’ll find:
- Eighty revenue and market share exhibits that are also presented in a standalone Excel file. These include:
- 2019 vs. 2018 revenue estimates for the 43 largest companies (revenue above $199 million) and market share for the top seven
- 2019 vs. 2018 revenue estimates and market share for the top players in each market segment (joint replacement knee, hip, and extremities; spine; trauma; sports medicine; orthobiologics and contract manufacturers)
- 2019 U.S., EMEA, Asia Pacific and Rest of World revenue for the top thirteen companies and others
- Growth rates for the largest players in each segment
- 2017 through 2022 year-over-year projections for the industry overall and each market segment
- A summary of influences that shape the industry and each market segment
- A recap of 2019 strategic activity, including acquisitions, FDA 510(k) clearances, product launches, and funding
- Lists of companies that play in each market segment and the subsegments within which they sell products
- Market drivers and advice regarding the current and critical opportunities and challenges driving the industry. These include:
- The COVID-19 pandemic
- Ambulatory Surgical Centers (ASCs) and outpatient care settings
- New materials
- Mergers & acquisitions in companies and hospitals
- Robotics, computer-assisted surgery and connected ecosystems of products
A Contract Manufacturing chapter that details the sector’s size and market forces. These companies are seen as an extension of device manufacturers’ operations; therefore, they face similar market influences, including consolidation, global expansion, and personnel challenges.
A list of companies that received their first FDA 510(k) clearances and companies that received their first 510(k) clearance in a new market segment, as well as details on the company’s product and headquarter country.
Venture capitalists, financial analysts, device companies, suppliers, consultants, and entrepreneurial-minded surgeons utilize components of this report to set strategy, prioritize actions and move their companies, their initiatives, and their careers-forward.
Users tell us that they use the report to:
- Identify Acquisition Targets and New Customers
- Improve Sales Forecasts
- Bolster Business Plans
- Refine Competitive Analysis
- Expand Your Perspective on Crucial Orthopedic Market Dynamics
- Advance Your Position Inside and Outside Your Company
- Educate New Hires and Veteran Team Members
Key Topics Covered
PREFACE
NUMBERS AND SEGMENTS
EXECUTIVE SUMMARY
- Situation Analysis
- Performance Overview
- Product Segments
- Exhibit 1: Orthopedic Product Segment Sales – 2017 to 2019
- Exhibit 2: Market Share by Product Segment – 2017 to 2019
- Exhibit 3: Orthopedic Product Segment Sales by 2019 Market Share
- Company Performance
- Exhibit 4: Total Orthopedic Product Sales – 2017 to 2019
- Exhibit 5: Market Share – Largest Players and All Others
- Exhibit 6: Top Tier Company Sales by Market Segment
- Exhibit 7: Total Orthopedic Sales – Players Between $400 and $999 Million
- Exhibit 8: Total Orthopedic Sales – Companies Over $400 Million
- Exhibit 9: Growth Rates for the Largest Orthopedic Companies
- Exhibit 10: Total Orthopedic Sales – Players Between $200 and $399 Million
- Exhibit 11: Total Orthopedic Sales – Players Between $100 and $199 Million
- Exhibit 12: Orthopedic Sales by Geographic Region
- Exhibit 13: Orthopedic Sales Performance by Geographic Region
- Market Forecasts
- Exhibit 14: Orthopedic Sales – 2017 to 2022
- Exhibit 15: Orthopedic Sales Trajectory – 2017 to 2022
JOINT REPLACEMENT
- Market & Players Review
- Exhibit 16: Joint Replacement Market Share
- Exhibit 17: Joint Replacement Sales – 2017 to 2019
- Exhibit 18: Joint Replacement Sales by Segment
- Exhibit 19: Joint Replacement Sales – Players Over $100 Million and All Others
- Exhibit 20: Joint Replacement Market Share – Top 10 Players and All Others
- Exhibit 21: Largest Joint Replacement Companies by Revenue
- Exhibit 22: Growth Rates for the Largest Joint Replacement Companies by Revenue
- Robotics and Enabling Technologies in Joint Replacement
- Knees
- Exhibit 23: Knee Market Share
- Exhibit 24: Knee Sales – 2017 to 2019
- Exhibit 25: Knee Sales – Players Over $50 Million and All Others
- Exhibit 26: Knee Market Share – Top 10 Players and All Others
- Exhibit 27: 10 Largest Knee Companies by Revenue
- Exhibit 28: Growth Rates for the 10 Largest Knee Companies
- Hips
- Exhibit 29: Hip Market Share
- Exhibit 30: Hip Sales – 2017 to 2019
- Exhibit 31: Hip Sales – Players Over $50 Million and All Others
- Exhibit 32: Hip Market Share – Top 10 Players and All Others
- Exhibit 33: 10 Largest Hip Companies by Revenue
- Exhibit 34: Growth Rates for the 10 Largest Hip Players
- Extremities
- Exhibit 35: Extremities Joint Market Share
- Exhibit 36: Extremities Joint Sales – 2017 to 2019
- Exhibit 37: Extremities Joint Sales – Players Over $50 Million and All Others
- Exhibit 38: Extremities Market Share – Top 9 Players and All Others
- Exhibit 39: 9 Largest Extremities Companies by Revenue
- Exhibit 40: Growth Rates for the 9 Largest Extremities Companies
- Joint Replacement Market Forecast
- Exhibit 41: Joint Replacement Sales – 2017 to 2022
- Exhibit 42: Joint Replacement Sales Trajectory – 2017 to 2022
- Companies to Watch
- Corin Enters Robotics Market with OMNI Acquisition
- LimaCorporate Expands Enabling Technology, 3D Printing Portfolio
- DT MedTech Expands with New Total Ankle in U.S. Market
- Product Launches & Technologies
- Strategic Product Launches in 2019
- Companies with First FDA 510(k) in 2019
SPINE
- Market & Players Review Exhibit 43: Spine Market Share
- Exhibit 44: Spine Sales – 2017 to 2019
- Exhibit 45: Spine Sales by Segments
- Exhibit 46: Spine Sales – Players Over $50 Million and All Others
- Exhibit 47: Spine Sales Growth Rates – Spine Focused and Diversified Players
- Exhibit 48: Spine Market Share – Top 11 Players and All Others
- Market Forecast
- Exhibit 49: Spine Sales – 2017 to 2022
- Exhibit 50: Spine Sales Trajectory – 2017 to 2022
- Companies to Watch
- ATEC’s Painful Road Back to Relevance in Spine
- MiRus Receives FDA 510(k) Clearance for Implant with New Superalloy
- SI-BONE Double-Digit Growth Fueled by Reimbursement Wins
- Product Launches & Technologies
- Strategic Product Launches in 2019
- Companies with First FDA 510(k) in 2019
TRAUMA
- Market & Players Review
- Exhibit 51: Trauma Market Share
- Exhibit 52: Trauma Sales – 2017 to 2019
- Exhibit 53: Trauma Sales – Players Over $50 Million and All Others
- Exhibit 54: 12 Largest Trauma Players by Sales
- Exhibit 55: Trauma Market Share – Top 12 Players and All Others
- Exhibit 56: Growth Rates for the 12 Largest Trauma Companies
- Market Forecast
- Exhibit 57: Trauma Sales – 2017 to 2022
- Exhibit 58: Trauma Sales Trajectory – 2017 to 2022
- Companies to Watch
- OrthoPediatrics Eyeing $100 Million Mark, $50 Million in Trauma
- Paragon 28 Growth Backed by Aggressive Product Development
- Product Launches & Technologies
- Strategic Product Launches in 2019
- Companies with First FDA 510(k) in 2019
SPORTS MEDICINE
- Market & Players Review
- Exhibit 59: Sports Medicine Market Share
- Exhibit 60: Sports Medicine Sales – 2017 to 2019
- Exhibit 61: Sports Medicine Sales – Players Over $100 Million and All Others
- Exhibit 62: 7 Largest Sports Medicine Companies by Revenue
- Exhibit 63: Sports Medicine Market Share – Top 7 Players and All Others
- Exhibit 64: Growth Rates for the 7 Largest Sports Medicine Companies
- Market Forecast
- Exhibit 65: Sports Medicine Sales – 2017 to 2022
- Exhibit 66: Sports Medicine Sales Trajectory – 2017 to 2022
- Companies to Watch
- ConMed Looks to New Products and Sales Structure to Maintain Growth
- Anika Diversifies Revenue Mix Through Regenerative Medicine
- Product Launches & Technologies
- Strategic Product Launches in 2019
- Companies with First FDA 510(k) in 2019
ORTHOBIOLOGICS
- Market & Players Review
- Exhibit 67: Orthobiologics Market Share
- Exhibit 68: Orthobiologics Sales – 2017 to 2019
- Exhibit 69: Orthobiologics Sales – Players Over $50 Million and All Others
- Exhibit 70: Orthobiologics Market Share – Top 11 Players and All Others
- Exhibit 71: 11 Largest Orthobiologics Companies by Revenue
- Exhibit 72: Growth Rates for the 11 Largest Orthobiologics Companies
- Market Forecast Exhibit 73: Orthobiologics Sales – 2017 to 2022
- Exhibit 74: Orthobiologics Sales Trajectory – 2017 to 2022
- Companies to Watch
- SeaSpine Doubles Down on DBMS with OsteoStrand
- Vericel: A High Growth Story with Staying Power
- Product Launches & Technologies
- Strategic Product Launches in 2019
CONTRACT MANUFACTURING
- Market & Players Review Exhibit 75: Contract Manufacturing Orthopedic Sales – 2017 to 2019
- Exhibit 76: Contract Manufacturing Orthopedic Sales – Players Over $100 Million
- Exhibit 77: Contract Manufacturing Orthopedic Market Share – Top 7 Players and All Others
- Exhibit 78: Top 10 Contract Manufacturers by Orthopedic Revenue Rank
- Market Forecast
- Exhibit 79: Contract Manufacturing Sales – 2017 to 2022
- Exhibit 80: Contract Manufacturing Trajectory – 2017 to 2022
- Companies to Watch
- Jabil Creates Formal Healthcare Group
- Lincotek Positioned as a Top Supplier with CoorsTek Acquisition
- Capability and Certification Expansions
- Equipment and Facility Expansions
APPENDICES
Appendix A: 2019 FDA 510(K)s
Appendix B: 2019 Funding
Appendix C: Contract Manufacturer M&A
Appendix D: Device and Orthobiologic Company M&A
Appendix E: Joint Replacement
Appendix F: Spine
Appendix G: Trauma
Appendix H: Sports Medicine
Appendix I: Orthobiologics
Appendix J: Robotics & Digital Surgery
Companies Mentioned
- Acumed
- Aesculap
- Alphatec/ATEC Spine
- Amplitude
- Anika Therapeutics
- Arthrex
- Arthrosurface
- Autocam Medical
- Avalign
- Bioventus
- CeramTec
- Conformis
- ConMed
- Corin
- Cretex Companies
- CrossRoads Extremity Systems
- DePuy Synthes
- DJO
- Elos Medtech
- EOS imaging
- Episurf Medical
- Evolutis
- Exactech
- Globus Medical
- GS Medical
- HAPPE Spine
- Heraeus
- Implantcast
- Intech
- Integra LifeSciences
- KARL STORZ
- Kyocera
- LifeNet Health
- LimaCorporate
- Mathys
- Medacta
- Medartis
- Medtronic
- MicroPort Orthopedics
- MiRus
- MTF Biologics
- NN Life Sciences
- NuVasive
- Orchid Orthopedic Solutions
- Orthofix Medical
- OrthoPediatrics
- OsteoMed
- RTI Surgical
- SeaSpine
- Seikagaku
- Smith & Nephew
- Spineart
- Stryker
- Tecomet
- ulrich medical
- Viant
- Waldemar Link
- WishBone Medical
- Wright Medical
- Zimmer Biomet
For more information about this report visit here.